1. Establishment of highly invasive pancreatic cancer cell lines and the expression of IL‑32
   Kohji Takagi et al, 2020, Oncology Letters CrossRef
2. Interleukin-32 Gamma as a New Face in Inflammatory Bone Diseases
   Eun-Jin Lee et al, 2017, Journal of Rheumatic Diseases CrossRef
3. IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients
   Matheus Rodrigues Lopes et al, 2017, Applied Cancer Research CrossRef
4. Signaling pathways bridging microbial-triggered inflammation and cancer
   Maulilio John Kipanyula et al, 2013, Cellular Signalling CrossRef
5. Impact of intra-tumoral IL17A and IL32 gene expression on T-cell responses and lymph node status in breast cancer patients
   Shreyas Bhat et al, 2017, Journal of Cancer Research and Clinical Oncology CrossRef
6. A transcriptional metastatic signature predicts survival in clear cell renal cell carcinoma
   Adele M. Alchahin et al, 2022, Nature Communications CrossRef
7. Associations between Interleukin-32 Gene Polymorphisms rs12934561 and rs28372698 and Susceptibilities to Bladder Cancer and the Prognosis in Chinese Han Population
   Jie Yang et al, 2020, Disease Markers CrossRef
8. Interleukin-32α promotes the proliferation of multiple myeloma cells by inducing production of IL-6 in bone marrow stromal cells
   Xuanru Lin et al, 2017, Oncotarget CrossRef
9. Interleukin-32 in Infection, Inflammation and Cancer Biology
   Mladen Pavlovic et al, 2020, Serbian Journal of Experimental and Clinical Research CrossRef
10. BNP-Seq: Bayesian Nonparametric Differential Expression Analysis of Sequencing Count Data
    Siamak Zamani Dadaneh et al, 2018, Journal of the American Statistical Association CrossRef
11. IL-32 and its paradoxical role in neoplasia
    Jacob T. Hough et al, 2023, Critical Reviews in Oncology/Hematology CrossRef
12. Insights into the role of IL-32 in cancer
    Yvette J.E. Sloot et al, 2018, Seminars in Immunology CrossRef
13. Interleukin 32, inflammation and cancer
    Jin Tae Hong et al, 2017, Pharmacology & Therapeutics CrossRef
14. The Rest of Interleukins
    Arseniy E. Yuzhalin et al, 2015, Interleukins in Cancer Biology CrossRef
15. Role of signaling pathways in the interaction between microbial, inflammation and cancer
    Armel Hervé Nwabo Kamdje et al, 2023, Holistic Integrative Oncology CrossRef
16. Interleukin-32 stimulates osteosarcoma cell invasionand motility via AKT pathway-mediated MMP-13 expression
    ZHOU YANHONG et al, 2015, International Journal of Molecular Medicine CrossRef
17. Molecular interactions and functions of IL-32
    Kristin Roseth Aass et al, 2021, Journal of Leukocyte Biology CrossRef
18. Methylation-related genes involved in renal carcinoma progression
    Jose María Zamora-Fuentes et al, 2023, Frontiers in Genetics CrossRef
19. The expression of Eg5 predicts a poor outcome for patients with renal cell carcinoma
    Dingqi Sun et al, 2013, Medical Oncology CrossRef